ID   SMAD4_RAT               Reviewed;         552 AA.
AC   O70437;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   02-OCT-2024, entry version 169.
DE   RecName: Full=Mothers against decapentaplegic homolog 4;
DE            Short=MAD homolog 4;
DE            Short=Mothers against DPP homolog 4;
DE   AltName: Full=SMAD family member 4;
DE            Short=SMAD 4;
DE            Short=Smad4;
GN   Name=Smad4; Synonyms=Madh4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RA   Miyakita A., Okuno S., Watanabe T.K., Oga K., Tsuji A., Hishigaki H.,
RA   Suto T., Nakagawa K., Nakahara Y., Higashi K.;
RT   "Molecular cloning of rat Smad4 gene.";
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10670756; DOI=10.1507/endocrj.46.695;
RA   Osaki M., Tsukazaki T., Ono N., Yonekura A., Hirota Y., Miyazaki Y.,
RA   Shindo H., Sonta S., Yamashita S.;
RT   "cDNA cloning and chromosomal mapping of rat Smad2 and Smad4 and their
RT   expression in cultured rat articular chondrocytes.";
RL   Endocr. J. 46:695-701(1999).
RN   [3]
RP   INTERACTION WITH CITED2.
RX   PubMed=16619037; DOI=10.1038/sj.onc.1209552;
RA   Chou Y.T., Wang H., Chen Y., Danielpour D., Yang Y.C.;
RT   "Cited2 modulates TGF-beta-mediated upregulation of MMP9.";
RL   Oncogene 25:5547-5560(2006).
CC   -!- FUNCTION: Common SMAD (co-SMAD) is the coactivator and mediator of
CC       signal transduction by TGF-beta (transforming growth factor). Component
CC       of the heterotrimeric SMAD2/SMAD3-SMAD4 complex that forms in the
CC       nucleus and is required for the TGF-mediated signaling. Promotes
CC       binding of the SMAD2/SMAD4/FAST-1 complex to DNA and provides an
CC       activation function required for SMAD1 or SMAD2 to stimulate
CC       transcription. Component of the multimeric SMAD3/SMAD4/JUN/FOS complex
CC       which forms at the AP1 promoter site; required for synergistic
CC       transcriptional activity in response to TGF-beta. Acts synergistically
CC       with SMAD1 and YY1 in bone morphogenetic protein (BMP)-mediated
CC       cardiac-specific gene expression. Binds to SMAD binding elements (SBEs)
CC       (5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac
CC       activating regions. May act as a tumor suppressor. Positively regulates
CC       PDPK1 kinase activity by stimulating its dissociation from the 14-3-3
CC       protein YWHAQ which acts as a negative regulator. In muscle physiology,
CC       plays a central role in the balance between atrophy and hypertrophy.
CC       When recruited by MSTN, promotes atrophy response via phosphorylated
CC       SMAD2/4. MSTN decrease causes SMAD4 release and subsequent recruitment
CC       by the BMP pathway to promote hypertrophy via phosphorylated SMAD1/5/8
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer; in the absence of TGF-beta activation (By
CC       similarity). Heterotrimer; on TGF-beta activation (By similarity).
CC       Heterotrimer composed of two molecules of a C-terminally phosphorylated
CC       R-SMAD molecule, SMAD2 or SMAD3, and one molecule of SMAD4 to form the
CC       transcriptional active SMAD2/SMAD3-SMAD4 complex (By similarity). Found
CC       in a ternary complex composed of SMAD4, STK11/LKB1 and STK11IP. Found
CC       in a complex with SMAD1 and YY1. Identified in a complex that contains
CC       at least ZNF451, SMAD2, SMAD3 and SMAD4 (By similarity). Interacts with
CC       ATF2, COPS5, DACH1, MSG1, SKI, STK11/LKB1, STK11IP and TRIM33.
CC       Associates with ZNF423 or ZNF521 in response to BMP2 leading to
CC       activate transcription of BMP target genes. Interacts with USP9X.
CC       Interacts with RBPMS. Interacts with WWTR1 (via coiled-coil domain).
CC       Interacts with CITED1 and CITED2. Interacts with PDPK1 (via PH domain).
CC       Interacts with VPS39; this interaction affects heterodimer formation
CC       with SMAD3, but not with SMAD2, and leads to inhibition of SMAD3-
CC       dependent transcription activation. Interactions with VPS39 and SMAD2
CC       may be mutually exclusive (By similarity). Interacts (via MH2 domain)
CC       with ZNF451 (via N-terminal zinc-finger domains) (By similarity).
CC       Interacts with ZC3H3 (By similarity). Interacts weakly with ZNF8 (By
CC       similarity). Interacts with NUP93 and IPO7; translocates SMAD4 to the
CC       nucleus through the NPC upon BMP7 stimulation resulting in activation
CC       of SMAD4 signaling (By similarity). Interacts with CREB3L1, the
CC       interaction takes place upon TGFB1 induction and SMAD4 acts as a
CC       CREB3L1 coactivator to induce the expression of genes involved in the
CC       assembly of collagen extracellular matrix (By similarity). Interacts
CC       with DLX1 (By similarity). Interacts with ZBTB7A; the interaction is
CC       direct and stimulated by TGFB1 (By similarity). Interacts with CREBBP;
CC       the recruitment of this transcriptional coactivator is negatively
CC       regulated by ZBTB7A (By similarity). Interacts with EP300; the
CC       interaction with this transcriptional coactivator is negatively
CC       regulated by ZBTB7A (By similarity). Interacts with HDAC1 (By
CC       similarity). Interacts (via MH2 domain) with ZMIZ1 (via SP-RING-type
CC       domain); in the TGF-beta signaling pathway increases the activity of
CC       the SMAD3/SMAD4 transcriptional complex (By similarity). Interacts (via
CC       N-terminus) with TSC22D1 (By similarity).
CC       {ECO:0000250|UniProtKB:P97471, ECO:0000250|UniProtKB:Q13485,
CC       ECO:0000269|PubMed:16619037}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q13485}. Nucleus
CC       {ECO:0000250|UniProtKB:Q13485}. Note=In the cytoplasm in the absence of
CC       ligand. Migration to the nucleus when complexed with R-SMAD. PDPK1
CC       prevents its nuclear translocation. {ECO:0000250|UniProtKB:Q13485}.
CC   -!- DOMAIN: The MH1 domain is required for DNA binding. {ECO:0000250}.
CC   -!- DOMAIN: The MH2 domain is required for both homomeric and heteromeric
CC       interactions and for transcriptional regulation. Sufficient for nuclear
CC       import (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated by PDPK1. {ECO:0000250}.
CC   -!- PTM: Monoubiquitinated on Lys-519 by E3 ubiquitin-protein ligase
CC       TRIM33. Monoubiquitination hampers its ability to form a stable complex
CC       with activated SMAD2/3 resulting in inhibition of TGF-beta/BMP
CC       signaling cascade. Deubiquitination by USP9X restores its competence to
CC       mediate TGF-beta signaling (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the dwarfin/SMAD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB010954; BAA83092.1; -; mRNA.
DR   EMBL; AF056002; AAC12781.1; -; mRNA.
DR   RefSeq; NP_062148.1; NM_019275.3.
DR   AlphaFoldDB; O70437; -.
DR   SMR; O70437; -.
DR   IntAct; O70437; 1.
DR   MINT; O70437; -.
DR   STRING; 10116.ENSRNOP00000074882; -.
DR   iPTMnet; O70437; -.
DR   PhosphoSitePlus; O70437; -.
DR   jPOST; O70437; -.
DR   PaxDb; 10116-ENSRNOP00000021113; -.
DR   Ensembl; ENSRNOT00000082484.2; ENSRNOP00000074882.2; ENSRNOG00000051965.2.
DR   Ensembl; ENSRNOT00055016774; ENSRNOP00055013530; ENSRNOG00055009888.
DR   Ensembl; ENSRNOT00060014901; ENSRNOP00060011548; ENSRNOG00060008865.
DR   Ensembl; ENSRNOT00065039225; ENSRNOP00065031862; ENSRNOG00065022934.
DR   GeneID; 50554; -.
DR   KEGG; rno:50554; -.
DR   AGR; RGD:3033; -.
DR   CTD; 4089; -.
DR   RGD; 3033; Smad4.
DR   eggNOG; KOG3701; Eukaryota.
DR   GeneTree; ENSGT00940000157435; -.
DR   InParanoid; O70437; -.
DR   OMA; CWIEVQI; -.
DR   OrthoDB; 5395671at2759; -.
DR   PhylomeDB; O70437; -.
DR   Reactome; R-RNO-1181150; Signaling by NODAL.
DR   Reactome; R-RNO-1502540; Signaling by Activin.
DR   Reactome; R-RNO-201451; Signaling by BMP.
DR   Reactome; R-RNO-2173789; TGF-beta receptor signaling activates SMADs.
DR   Reactome; R-RNO-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-RNO-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-RNO-8941855; RUNX3 regulates CDKN1A transcription.
DR   Reactome; R-RNO-9617828; FOXO-mediated transcription of cell cycle genes.
DR   PRO; PR:O70437; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   GO; GO:0032444; C:activin responsive factor complex; ISO:RGD.
DR   GO; GO:0005813; C:centrosome; IEA:Ensembl.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0071144; C:heteromeric SMAD protein complex; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0071141; C:SMAD protein complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0005518; F:collagen binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IDA:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0031005; F:filamin binding; IPI:RGD.
DR   GO; GO:0070411; F:I-SMAD binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0070412; F:R-SMAD binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0046332; F:SMAD binding; IPI:RGD.
DR   GO; GO:0043199; F:sulfate binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; ISO:RGD.
DR   GO; GO:0001222; F:transcription corepressor binding; ISO:RGD.
DR   GO; GO:0030325; P:adrenal gland development; IEP:RGD.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; ISO:RGD.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISO:RGD.
DR   GO; GO:0036302; P:atrioventricular canal development; ISO:RGD.
DR   GO; GO:0003190; P:atrioventricular valve formation; ISO:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0030509; P:BMP signaling pathway; ISO:RGD.
DR   GO; GO:0003360; P:brainstem development; ISO:RGD.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0014898; P:cardiac muscle hypertrophy in response to stress; IMP:RGD.
DR   GO; GO:0003279; P:cardiac septum development; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IDA:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:RGD.
DR   GO; GO:0048589; P:developmental growth; ISO:RGD.
DR   GO; GO:0006351; P:DNA-templated transcription; ISO:RGD.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; ISO:RGD.
DR   GO; GO:0060956; P:endocardial cell differentiation; ISO:RGD.
DR   GO; GO:0007492; P:endoderm development; ISO:RGD.
DR   GO; GO:0042118; P:endothelial cell activation; ISO:RGD.
DR   GO; GO:0010631; P:epithelial cell migration; ISO:RGD.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; ISO:RGD.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0008585; P:female gonad development; ISO:RGD.
DR   GO; GO:0061040; P:female gonad morphogenesis; ISO:RGD.
DR   GO; GO:0048859; P:formation of anatomical boundary; ISO:RGD.
DR   GO; GO:0007369; P:gastrulation; ISO:RGD.
DR   GO; GO:0001702; P:gastrulation with mouth forming second; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0070102; P:interleukin-6-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0003220; P:left ventricular cardiac muscle tissue morphogenesis; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; ISO:RGD.
DR   GO; GO:0048382; P:mesendoderm development; ISO:RGD.
DR   GO; GO:0007498; P:mesoderm development; ISO:RGD.
DR   GO; GO:0072133; P:metanephric mesenchyme morphogenesis; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; ISO:RGD.
DR   GO; GO:1905305; P:negative regulation of cardiac myofibril assembly; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0072134; P:nephrogenic mesenchyme morphogenesis; ISO:RGD.
DR   GO; GO:0014033; P:neural crest cell differentiation; ISO:RGD.
DR   GO; GO:0048663; P:neuron fate commitment; ISO:RGD.
DR   GO; GO:0048665; P:neuron fate specification; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; IMP:RGD.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; ISO:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; IEP:RGD.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0003251; P:positive regulation of cell proliferation involved in heart valve morphogenesis; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:1901203; P:positive regulation of extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0046881; P:positive regulation of follicle-stimulating hormone secretion; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0033686; P:positive regulation of luteinizing hormone secretion; ISO:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0060391; P:positive regulation of SMAD protein signal transduction; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0051797; P:regulation of hair follicle development; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032909; P:regulation of transforming growth factor beta2 production; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0071559; P:response to transforming growth factor beta; ISO:RGD.
DR   GO; GO:0048733; P:sebaceous gland development; ISO:RGD.
DR   GO; GO:0062009; P:secondary palate development; ISO:RGD.
DR   GO; GO:0072520; P:seminiferous tubule development; ISO:RGD.
DR   GO; GO:0007338; P:single fertilization; ISO:RGD.
DR   GO; GO:0060395; P:SMAD protein signal transduction; ISO:RGD.
DR   GO; GO:0032525; P:somite rostral/caudal axis specification; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   GO; GO:0048729; P:tissue morphogenesis; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0060065; P:uterus development; ISO:RGD.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISO:RGD.
DR   CDD; cd10492; MH1_SMAD_4; 1.
DR   CDD; cd10498; MH2_SMAD_4; 1.
DR   Gene3D; 2.60.200.10; -; 1.
DR   Gene3D; 3.90.520.10; SMAD MH1 domain; 1.
DR   InterPro; IPR013790; Dwarfin.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   InterPro; IPR013019; MAD_homology_MH1.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR001132; SMAD_dom_Dwarfin-type.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   InterPro; IPR036578; SMAD_MH1_sf.
DR   PANTHER; PTHR13703:SF63; MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 4; 1.
DR   PANTHER; PTHR13703; SMAD; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF03166; MH2; 1.
DR   SMART; SM00523; DWA; 1.
DR   SMART; SM00524; DWB; 1.
DR   SUPFAM; SSF56366; SMAD MH1 domain; 1.
DR   SUPFAM; SSF49879; SMAD/FHA domain; 1.
DR   PROSITE; PS51075; MH1; 1.
DR   PROSITE; PS51076; MH2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; DNA-binding; Isopeptide bond; Metal-binding;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc.
FT   CHAIN           1..552
FT                   /note="Mothers against decapentaplegic homolog 4"
FT                   /id="PRO_0000090864"
FT   DOMAIN          18..142
FT                   /note="MH1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00438"
FT   DOMAIN          323..552
FT                   /note="MH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00439"
FT   REGION          1..322
FT                   /note="Mediates interaction with ZBTB7A"
FT                   /evidence="ECO:0000250|UniProtKB:Q13485"
FT   REGION          44..69
FT                   /note="Required for interaction with TSC22D1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13485"
FT   REGION          167..193
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          275..320
FT                   /note="SAD"
FT   COMPBIAS        173..193
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         71
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         115
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         127
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         132
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   SITE            515
FT                   /note="Necessary for heterotrimerization"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         37
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13485"
FT   MOD_RES         428
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13485"
FT   MOD_RES         507
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13485"
FT   CROSSLNK        113
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13485"
FT   CROSSLNK        519
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13485"
SQ   SEQUENCE   552 AA;  60469 MW;  7AE0540AB4DF0E77 CRC64;
     MDNMSITNTP TSNDACLSIV HSLMCHRQGG ESETFAKRAI ESLVKKLKEK KDELDSLITA
     ITTNGAHPSK CVTIQRTLDG RLQVAGRKGF PHVIYARLWR WPDLHKNELK HVKYCQYAFD
     LKCDSVCVNP YHYERVVSPG IDLSGLTLQS NAPPSMLVKD EYVHDFEGQP SLPTEGHSIQ
     TIQHPPSNRA STETYSAPAL LAPSESNATS TTNFPNIPVA STSQPASILA GSHSEGLLQI
     ASGPQPGQQQ NGFTAQPATY HHNSTTTWTG SRTAPYTPNL PHHQNGHLQH HPPMPPHPGH
     YWPVHNELAF QPPISNHPAP EYWCSIAYFE MDVQVGETFK VPSSCPIVTV DGYVDPSGGD
     RFCLGQLSNV HRTEAIERAR LHIGKGVQLE CKGEGDVWVR CLSDHAVFVQ SYYLDREAGR
     APGDAVHKIY PSAYIKVFDL RQCHRQMQQQ AATAQAAAAA QAAAVAGNIP GPGSVGGIAP
     AISLSAAAGI GVDDLRRLCI LRMSFVKGWG PDYPRQSIKE TPCWIEIHLH RALQLLDEVL
     HTMPIADPQP LD
//
